Abstract
Neuroleptic malignant syndrome (NMS) has been recently described following therapy with non strictly neuroleptic drugs that alter dopaminergic function, such as sulpiride and metoclopramide, and might occur more easily in patients with functional or organic brain disorders. We observed an AIDS patient who suffered from NMS following treatment with clotiapine for insomnia and agitation. Two months later, he presented with a similar syndrome following antiemetic treatment with alizapride. On both occasions, the symptoms completely regressed after the administration of dopaminergic and muscle relaxant drugs. The patient died of pneumonia one month after the last episode. The present paper describes the clinical and pathological findings.
Original language | English |
---|---|
Pages (from-to) | 293-295 |
Number of pages | 3 |
Journal | Italian Journal of Neurological Sciences |
Volume | 15 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jan 1994 |
Keywords
- AIDS
- basal ganglia
- dopaminergic function
- neuroleptic malignant syndrome
ASJC Scopus subject areas
- Neuroscience(all)
- Clinical Neurology